Skip to content
BidBenchmark

Contractor

MARK CUBAN COST PLUS DRUG COMPANY, PBC

DALLAS, TX
UEI
N8P7MQ937WN7
Parent UEI
N8P7MQ937WN7
Resolved by
uei
Confidence
1.000
Obligated to date
$1,599,1791
Awards
2
Agencies served
1

Active from Jun 11, 2025 to Apr 10, 2026.

Sign in to watch

Recent awards

AwardAgencyPlaceFirst actionCurrent value
W911SR26CA011

MARK CUBAN COST PLUS DRUG COMPANY (MCCPDC) INTENDS TO GENERATE A CHEMISTRY, MANUFACTURING, AND CONTROLS (CMC) DATA PACKAGE SUITABLE FOR AN FDA ABBREVIATED NEW DRUG APPLICATION (ANDA).

Department of DefenseTXApr 10, 2026$1,393,259
W911SR25CA006

THIS CONTRACT IS FOR PROOF OF CONCEPT PRODUCTION OF DRUG SUBSTANCE STERILE SALINE AND STERILE WATER USING NONSTERILE SOURCE WATER MADE UNDER CURRENT GOOD MANUFACTURING PRACTICE REGULATIONS.

Department of DefenseTXJun 11, 2025$205,920

Sources and method

Figures on this page are computed from public federal award records. Numbers are never estimated or generated; where a figure is withheld, the reason is stated rather than filled in.

Totals sum obligations across every award attributed to this contractor. Obligations are cumulative funding actions, not the value of work delivered.

  1. 1Awards are attributed by Unique Entity Identifier N8P7MQ937WN7, the government's own recipient identifier, not by name matching.
  2. 2Award records from USAspending.gov, last refreshed Sep 12, 2026.